Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 16Urogenital Neoplasms 2Urinary Bladder Neoplasms 2Urothelial Cancer 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Radiation Injuries 1Prostate Adenocarcinoma 1Neoplasms by Site 1Neoplasms 1Melanoma 1Male Urogenital Diseases 1Lymphatic Metastasis 1Infiltrating Bladder Urothelial Carcinoma 1Genital Neoplasms, Male 1Female Urogenital Diseases 1Encopresis 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 4Diet Therapy 2Brachytherapy 2Androgen Antagonists 2delta 24-sterol reductase 1Surveys and Questionnaires 1Sildenafil Citrate 1Serotonin Plasma Membrane Transport Proteins 1Radiosurgery 1Radiation Dose Hypofractionation 1Proton Therapy 1Menogaril 1Lisinopril 1Goserelin 1Early Intervention, Educational 1Arginine 1ArginMax 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Radiation Dose Hypofractionation × Genitourinary × Clear all
NCT04535908 2022-10-03

Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

Medical University of Graz

Phase NA Terminated
23 enrolled
Genitourinary

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡